New York Court Upholds $3 Million Arbitration Award Against Sun Pharmaceuticals in Acne Drug Dispute
In a notable decision, a New York federal court upheld an arbitration award of $3 million against Sun Pharmaceuticals, following a breach of agreement regarding an acne medication. This ruling confirmed the arbitrator’s determination that Sun Pharmaceuticals violated the terms by seeking regulatory approval to market a generic version of the drug in Canada. The…